Musculoskeletal comorbidities in cardiovascular disease, diabetes and respiratory disease: the impact on activity limitations; a representative population-based study
2011

Impact of Musculoskeletal Conditions on Activity Limitations in Chronic Diseases

Sample size: 115915 publication Evidence: moderate

Author Information

Author(s): Morgan Slater, Anthony V Perruccio, Elizabeth M Badley

Primary Institution: Toronto Western Research Institute, University Health Network, Toronto, Canada

Hypothesis

The study aims to quantify the contribution of musculoskeletal comorbidity to activity limitations in individuals with chronic cardiovascular disease, diabetes, or respiratory disease.

Conclusion

Musculoskeletal conditions significantly contribute to activity limitations in people with chronic diseases, suggesting a need for integrated prevention and management strategies.

Supporting Evidence

  • Comorbid arthritis and back problems significantly increased the risk of activity limitations across all index conditions.
  • Arthritis and back problems accounted for at least 13% and 9% of activity limitations in the index populations.
  • Older age, lower income, and increased weight were significantly associated with activity limitations.

Takeaway

People with heart disease, diabetes, or breathing problems often have additional issues like arthritis or back pain, which make it harder for them to stay active.

Methodology

Analysis of the 2005 Canadian Community Health Survey data using prevalence ratios and multivariate log-Poisson regression.

Potential Biases

Self-reported data may introduce bias in the assessment of chronic conditions and activity limitations.

Limitations

The study relies on self-reported data, which may lead to inaccuracies in chronic disease prevalence and does not establish causal relationships.

Participant Demographics

Participants were adults aged 20 and older, with a diverse representation of age, gender, race, and socioeconomic status.

Statistical Information

Confidence Interval

95% CI: 1.60 (1.53 - 1.67) for arthritis in cardiovascular disease

Digital Object Identifier (DOI)

10.1186/1471-2458-11-77

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication